PDL BioPharma Appoints Chief Accounting Officer

By 2015-06-24T14:30:00

PDL BioPharma, which manages a portfolio of patents and royalty assets, has appointed Steffen Pietzke as controller and chief accounting officer. Pietzke joins PDL from Ernst & Young, where he held the position of senior manager since 2013. Details inside.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership $499 Value offer

Full price one year membership with auto-renewal.

Membership $599

One-year only, no auto-renewal.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS
Already a Compliance Week member?